Does Sentinel Lymph Node Biopsy Influence Subsequent Management Decisions in Women With Breast Cancer ≥ 70 Years Old?

Gordon R DalyGavin P DowlingEman HamzaMa'en AlRawashdehAisling HegartyTarnum NazJason McGrathSindhuja NaidooEithne DowneyAbeeda ButtColm PowerArnold D K Hill

Published in: Clinical breast cancer (2024)

In this study, SLNB did not significantly influence subsequent management decisions in patients over 80 and should rarely be performed in this cohort. However, SLNB still had a role in patients aged 70-80 and should be used selectively in this cohort.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
radiation therapy
patient reported outcomes
neoadjuvant chemotherapy